2 ms·
Huh? NICE sets a cost-effectiveness threshold of about £20,000-30,000 per QALY gained from a drug[0]. There was even a controversy where a drug for pancreatic c
by matteoraso 2mo ago
Huh? NICE sets a cost-effectiveness threshold of about £20,000-30,000 per QALY gained from a drug[0]. There was even a controversy where a drug for pancreatic cancer was denied funding for this very reason[1].
[0]https://web.archive.org/web/20110925050527/http://www.nice.org.uk/niceMedia/pdf/GuidelinesManualChapter8.pdf https://web.archive.org/web/20110925050527/http://www.nice.o...
[1]https://web.archive.org/web/20151225115559/http://www.pancreaticcancer.org.uk/latest-news/2015/september/last-hope-dashed-for-access-to-life-extending-pancreatic-cancer-drug-on-the-nhs-in-england/#sthash.PpHk2Lur.dpuf https://web.archive.org/web/20151225115559/http://www.pancre...
- onraglanroad 2mo agoNICE is an independent body consisting mainly of medical professionals. It's not made up of MPs. That's exactly my point. How on earth are you still missing this?
- matteoraso 1mo agoIt's also overseen by the Minister of State at the Department of Health and Social Care. Also, how on Earth do you think insurance companies don't consult doctors on insurance denials?
- onraglanroad 1mo agoWhich was my point. The overseeing has to do with funding not application. But you're fundamentally dishonest here. You recognise insurance denials but are trying to pretend they don't exist. You're not discussing honestly, you're just a useless waste of space.